Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)
Invited conference paper presented and published in conference proceedings

Times Cited
Web of Science9WOS source URL (as at 18/09/2021) Click here for the latest count
Altmetrics Information

Other information
All Author(s) ListD Lim, HM Wang, SH Li, R Ngan, A Dechaphunkul, L Zhang, CJ Yen, PC Chan,S Chakrabandhu, B Ma, S Tanasanvimon, V Lee, PJ Lou, Zujun Li, A Spira, A Sukari,J Guigay, S McCune,Y Sun, S Szpakowski, Y Yao ,X Fan, L Manenti, C Even
Name of ConferenceAmerican Association for Cancer Research Annual Meeting 2019
Start Date of Conference29/03/2019
End Date of Conference03/04/2019
Place of ConferenceAtlanta, GA
Country/Region of ConferenceUnited States of America
Proceedings TitleCancer Research
Volume Number79
Issue NumberSuppl 13
Article numberAbstract CT150
LanguagesEnglish-United Kingdom

Last updated on 2021-19-09 at 00:45